Premium
NPM1 mutation but not RUNX1 mutation or multilineage dysplasia defines a prognostic subgroup within de novo acute myeloid leukemia lacking recurrent cytogenetic abnormalities in the revised 2016 WHO classification
Author(s) -
Weinberg Olga K.,
Gibson Christopher J.,
Blonquist Traci M.,
Neuberg Donna,
Pozdnyakova Olga,
Kuo Frank,
Ebert Benjamin L.,
Hasserjian Robert P.
Publication year - 2017
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.24739
Subject(s) - cebpa , npm1 , medicine , myeloid leukemia , context (archaeology) , oncology , leukemia , runx1 , disease , mutation , biology , karyotype , genetics , stem cell , gene , chromosome , paleontology , haematopoiesis